These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37119578)

  • 21. Zonisamide add-on therapy for focal epilepsy.
    Brigo F; Lattanzi S; Igwe SC; Behzadifar M; Bragazzi NL
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD001416. PubMed ID: 30335200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carbamazepine versus sulthiame in treating benign childhood epilepsy with centrotemporal spikes.
    Kramer U; Shahar E; Zelnik N; Lerman-Sagie T; Watemberg N; Nevo Y; Ben-Zeev B
    J Child Neurol; 2002 Dec; 17(12):914-6. PubMed ID: 12593467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of lacosamide in infants and young children with refractory focal epilepsy.
    Grosso S; Parisi P; Spalice A; Verrotti A; Balestri P
    Eur J Paediatr Neurol; 2014 Jan; 18(1):55-9. PubMed ID: 24129195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stiripentol for focal refractory epilepsy.
    Brigo F; Storti M; Igwe SC
    Cochrane Database Syst Rev; 2015 Oct; (10):CD009887. PubMed ID: 26488459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pregabalin adjunctive therapy for focal onset seizures in children 1 month to <4 years of age: A double-blind, placebo-controlled, video-electroencephalographic trial.
    Mann D; Antinew J; Knapp L; Almas M; Liu J; Scavone J; Yang R; Modequillo M; Makedonska I; Ortiz M; Kyrychenko A; Nordli D; Farkas V; Farkas MK;
    Epilepsia; 2020 Apr; 61(4):617-626. PubMed ID: 32189338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gabapentin add-on treatment for drug-resistant focal epilepsy.
    Panebianco M; Al-Bachari S; Hutton JL; Marson AG
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD001415. PubMed ID: 33434292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and tolerability of perampanel as a first add-on therapy with different anti-seizure drugs.
    Santamarina E; Bertol V; Garayoa V; García-Gomara MJ; Garamendi-Ruiz I; Giner P; Aranzábal I; Piera A; Arcos C; Esteve P; Marinas A; García-Escrivá A; Viloria-Alebesque A; Loro FA; de Tienda AP; Olivan JA; Bonet M; Dávila-González P; Sivera R; Molins A; Sansa G; Roche JC; Martínez AB; Monteagudo S; Casadevall T
    Seizure; 2020 Dec; 83():48-56. PubMed ID: 33096456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness and tolerability of adjunctive brivaracetam in patients with focal seizures: Second interim analysis of 6-month data from a prospective observational study in Europe.
    Steinhoff BJ; Christensen J; Doherty CP; Majoie M; De Backer M; Hellot S; Leunikava I; Leach JP
    Epilepsy Res; 2020 Sep; 165():106329. PubMed ID: 32623096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vigabatrin add-on therapy for drug-resistant focal epilepsy.
    Bresnahan R; Gianatsi M; Maguire MJ; Tudur Smith C; Marson AG
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD007302. PubMed ID: 32730657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-Term Safety, Tolerability, and Efficacy of Cannabidiol in Children with Refractory Epilepsy: Results from an Expanded Access Program in the US.
    Sands TT; Rahdari S; Oldham MS; Caminha Nunes E; Tilton N; Cilio MR
    CNS Drugs; 2019 Jan; 33(1):47-60. PubMed ID: 30460546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lamotrigine add-on for drug-resistant partial epilepsy.
    Ramaratnam S; Panebianco M; Marson AG
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD001909. PubMed ID: 27329345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rufinamide add-on therapy for drug-resistant epilepsy.
    Panebianco M; Prabhakar H; Marson AG
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD011772. PubMed ID: 33179247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Duration of focal complex, secondarily generalized tonic-clonic, and primarily generalized tonic-clonic seizures--A video-EEG analysis.
    Dobesberger J; Ristić AJ; Walser G; Kuchukhidze G; Unterberger I; Höfler J; Amann E; Trinka E
    Epilepsy Behav; 2015 Aug; 49():111-7. PubMed ID: 25935513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of sulthiame on EEG in children with benign childhood epilepsy with centrotemporal spikes (BECTS).
    Bast T; Völp A; Wolf C; Rating D;
    Epilepsia; 2003 Feb; 44(2):215-20. PubMed ID: 12558577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Levetiracetam vs. sulthiame in benign epilepsy with centrotemporal spikes in childhood: a double-blinded, randomized, controlled trial (German HEAD Study).
    Borggraefe I; Bonfert M; Bast T; Neubauer BA; Schotten KJ; Maßmann K; Noachtar S; Tuxhorn I; May TW; Heinen F;
    Eur J Paediatr Neurol; 2013 Sep; 17(5):507-14. PubMed ID: 23642492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review.
    Nevitt SJ; Sudell M; Tudur Smith C; Marson AG
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012065. PubMed ID: 31233229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Seizure outcome after AED failure in pediatric focal epilepsy: impact of underlying etiology.
    Wirrell EC; Wong-Kisiel LC; Nickels KC
    Epilepsy Behav; 2014 May; 34():20-4. PubMed ID: 24681380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term efficacy of add-on stiripentol treatment in children, adolescents, and young adults with refractory epilepsies: A single center prospective observational study.
    Rosati A; Boncristiano A; Doccini V; Pugi A; Pisano T; Lenge M; De Masi S; Guerrini R
    Epilepsia; 2019 Nov; 60(11):2255-2262. PubMed ID: 31630399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: results from a double-blind, randomized, placebo-controlled trial.
    Ryvlin P; Werhahn KJ; Blaszczyk B; Johnson ME; Lu S
    Epilepsia; 2014 Jan; 55(1):47-56. PubMed ID: 24256083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sulthiame in the primary therapy of West syndrome: a randomized double-blind placebo-controlled add-on trial on baseline pyridoxine medication.
    Debus OM; Kurlemann G;
    Epilepsia; 2004 Feb; 45(2):103-8. PubMed ID: 14738417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.